Back to mobile site

More on CING

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (8/18/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Cingulate Inc (NQ:CING)
Delayed: 4.99 -0.13 (2.54%)
Prev. Close $5.12  
Open$5.10 
52 Wk High$ 
52 Wk Low$ 
Day High$5.23 
Day Low$4.93 
P/E N/A  
EPS$ 
Volume506,499 

Friends, Peers and Foes (?): CINGW (more...)

Jun 16, 2026 08:10 AM Form 8-K Cingulate Inc. For: Jun 16
Jun 16, 2026 08:02 AM Cingulate receives first U.S. patent for ADHD drug candidate CTx-1301
Jun 16, 2026 08:01 AM Cingulate Issued First U.S. Patent for Lead ADHD Asset CTx-1301
Jun 8, 2026 07:02 PM Form 4 Cingulate Inc. For: Feb 13 Filed by: Hargroves Thomas Jeffrey
Jun 8, 2026 07:00 PM Form 3 Cingulate Inc. For: Feb 13 Filed by: Hargroves Thomas Jeffrey
Jun 4, 2026 04:50 PM Stonegate Capital Partners Updates Coverage on Cingulate Inc. (CING) 1Q26
Jun 2, 2026 08:10 AM Form 8-K Cingulate Inc. For: Jun 02
Jun 2, 2026 08:01 AM FDA issues complete response letter for Cingulate's ADHD drug CTx-1301
Jun 2, 2026 08:00 AM Cingulate Receives Complete Response Letter from FDA for CTx-1301
Jun 2, 2026 07:59 AM Cingulate Inc (CING) Halted News Pending
View All Articles

Entities mentioned with CING

View All Entities